AstraZeneca(AZN) - 2024 Q2 - Earnings Call Transcript

AstraZeneca PLC (NASDAQ:AZN) Q2 2024 Earnings Conference Call July 25, 2024 6:45 AM ET Company Participants Andy Barnett - Head, IR Pascal Soriot - Executive Director & CEO Aradhana Sarin - Executive Director & CFO David Fredrickson - EVP, Oncology Business Susan Galbraith - EVP, Oncology Research and Development Ruud Dobber - EVP & President, BioPharmaceuticals Sharon Barr - EVP, BioPharmaceuticals Research and Development Marc Dunoyer - CEO, Alexion and Chief Strategy Officer, AstraZeneca Dave Fredrickson ...